Announcing the MRC Centre for Drug Safety Science, ABPI, MHRA and RCUK/EPSRC workshop “Benefits and Risks of Nanomedicine”
The MRC Centre for Drug Safety Sciences is holding a series of workshops, in conjunction with the ABPI and the MHRA, addressing the challenges facing drug safety science in a number of areas. Through this series we announce the “Benefits and Risks of Nanomedicine” workshop in collaboration with the EPSRC/RCUK Nanotechnology Grand Challenges: Healthcare programme at the University of Liverpool.
The development of Nanomedicines is a rapidly developing commercial activity, a growing academic discipline and an emerging area of importance for drug safety science. During the workshop we aim to define challenges facing drug safety and importantly to identify solutions to these challenges through progressing our scientific understanding and fostering collaboration between all interested parties (industry, academia and regulatory bodies).
The workshop is being held on the 7thOctober 2010 at the University of Liverpool, UK. The organisers of the workshop (Steve Rannard, UoL and Andrew Owen, UoL) have created an programme of leading academics and industrial experts and would like to invite you to attend and participate in the event and planned debate. An agenda is attached for additional information. Please pass this invitation to other relevant colleagues if you are unable to attend.
The workshop is a not-for-profit event and there is a small registration fee of £200 for industry/regulatory representatives and £100 for academics. If you would like to register for this event please click here.
Or contact Hugh Laverty (Centre for Drug Safety Science) at Hugh.Laverty@liv.ac.uk for more details.